Abstract:Statins, the 3-hydroxy-3-methylglutaryl-cooenzyme A (HMG-CoA) reductase inhibitors, have been shown to inhibit the migration of macrophages and smooth muscle cell proliferation leading to an antiproliferative effect. Although this beneficial effect of statins has been suggested to be independent of lipid lowering properties, the possible mechanisms responsible for this action is largely unknown. Gap junctions, which serve as channels for direct intercellular exchange of ions, secondary messengers, and small signaling molecules, play an important role in tissue homeostasis and regulation of growth, differentiation, and development. This study was designed to test the hypothesis that expression of the component proteins of gap junctions, connexins 40 and 43 (Cx40 and Cx43), is upregulated in arteries subjected to balloon injury and that this upregulation can be suppressed by statin therapy. Male New Zealand white rabbits were subjected to injury in which an angioplasty catheter was introduced into the right iliac artery from the femoral artery under fluoroscopic guidance. Five groups of rabbits (n = 6 to 7) were treated for 2 weeks with one of the following: balloon injury (BL); BL+lovastatin (BL+L, 10 mg/kg/day); BL+fluvastatin (BL+F, 10 mg/kg/day); sham operation (Sham); and control (Con). Immunohistochemistry studies showed that Cx40 and Cx43 were expressed in normal smooth muscle cells (SMC) throughout the media. Reverse transcription-polymerase chain reaction and Western blot analysis showed that Cx40 and Cx43 mRNA and protein expression was elevated after injury (P < .001 for both proteins and both assays), and these elevations were suppressed by lovastatin and fluvastatin to a similar degree (P < .05 for both drugs and both assays). Immunostaining of Cx40 and Cx43 was consistently enhanced in the neointimal area after injury and lovastatin and fluvastatin reduced staining of these proteins in the lessened neointimal layer. Transmission electron microscopy revealed that there were abundant gap junctions between neointimal SMC as well as fewer and smaller gap junctions after statin treatment. Therefore, balloon injury causes upregulation of Cx40 and Cx43 in neointimal SMC. Lovastatin and fluvastatin suppress upregulated Cx40 and Cx43 expression and reduce neointimal proliferation, suggesting that Cx40 and Cx43 may play a role in statin-induced antiproliferative effect.

Effect of antiproliferative agents on vascular function in normal and in vitro balloon-injured porcine coronary arteries

Locally administered antiproliferative drugs inhibit hypercontractility to serotonin in balloon-injured pig coronary artery

Regulation of Connexin Expression after Balloon Injury: Possible Mechanisms for Antiproliferative Effect of Statins.

[Effect of Testosterone on Neointimal Proliferation and Blood Lipids after Balloon-Induced Aorta Injury in Rabbits].

Inhibitory Effects of Paclitaxel on Rat Graft Arteriosclerosis

Effects of Paclitaxel on the Intimal Proliferation in Rat Aortic Allografts

Comparative Evaluation of Local and Downstream Responses in Two Commercially Available Paclitaxel-Coated Balloons in Healthy Peripheral Arteries of a Swine Model

Effects of Certain Vasoactive Peptides on Pathogenesis of Vascular Restenosis.

The study of antiproliferation agent paclitaxel on preventing graft arterioscleriosis

Paclitaxel Protects against Isoproterenol-Induced Damage in Rat Myocardium: Its Heme-Oxygenase Mediated Role in Cardiovascular Research

Paclitaxel exerts antiplatelet and antithrombotic activities: Additional benefit from use of paclitaxel-coated balloons and -eluting stents in coronary revascularization and prevention of in-stent restenosis

Taxol Inhibits Stretch-Induced Electrophysiological Alterations in Isolated Rat Hearts with Acute Myocardial Infarction.

Different growth response of rabbit's vascular endothelial and smooth muscle cells to Paclitaxel

[Roles of Galphaq/11 Mediated- and Platelet-Derived Growth Factor Mediated-Signal Transduction Pathways in Rat Aorta Restenosis].

Alleviating iatrogenic effects of paclitaxel via antiinflammatory treatment

Drug-Coated Balloons: Drugs Beyond Paclitaxel?

Effect of Paclitaxel+Hirudin on the TLR4-MyD88 Signaling Pathway During Inflammatory Activation of Human Coronary Artery Smooth Muscle Cells and Mechanistic Analysis

Impact Assessment of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Hemostatic Sponge on Vascular Anastomosis Regeneration in Rats

Antiproliferative agent attenuates postthrombotic vein wall remodeling in murine and human subjects

Effect of Active Oxygen Species on Intimal Proliferation in Rat Aorta after Arterial Injury

Effects of Paclitaxel-eluting Stent on Blood Vessel Endothelial Function